FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2015423024> ?p ?o ?g. }

• W2015423024 endingPage "1770" @default.
• W2015423024 startingPage "1759" @default.
• W2015423024 abstract "Dasatinib is a potent tyrosine kinase inhibitor that is used to treat chronic myeloid leukemia in patients resistant or intolerant to imatinib mesylate. While designed to inhibit Abl and Src kinases, dasatinib shows multitarget effects, including inhibition of the macrophage colony-stimulating factor (M-CSF) receptor c-fms. We have shown previously that dasatinib abrogates osteoclast formation and activity in vitro owing, in part, to its specificity for c-fms. In this study we examined whether dasatinib could significantly alter bone volume in a model of physiologic bone turnover. Sprague-Dawley rats were administered dasatinib (5 mg/kg/day) or vehicle by gavage or zoledronic acid (ZOL; 100 microg/kg/6 weeks) subcutaneously. Following 4, 8, and 12 weeks of treatment, serum biochemical, bone morphometric, and histologic analyses were performed. Whole-body bone mineral density and tibial cortical thickness where unchanged in the dasatinib- or ZOL-treated animals relative to controls. However, micro-computed tomographic (microCT) analysis of cancellous bone at the proximal tibias showed that trabecular volume (BV/TV) and thickness (Tb.Th) were increased in dasatinib-treated animals at levels comparable with those of the ZOL-treated group. These changes were associated with a decrease in osteoclast numbers (N.Oc/B.Pm) and surface (Oc.S/BS) and decreased serum levels of the osteoclast marker c-terminal collagen crosslinks (CTX-1). Mineral apposition rate (MAR), bone-formation rate (BFR), and levels of the serum osteoblast markers osteocalcin and N-terminal propeptide of type I procollagen (P1NP) were not altered significantly in the dasatinib-treated animals relative to controls. These studies show that dasatinib increases trabecular bone volume at least in part by inhibiting osteoclast activity, suggesting that dasatinib therapy may result in dysregulated bone remodeling." @default.
• W2015423024 created "2016-06-24" @default.
• W2015423024 creator A5011048271 @default.
• W2015423024 creator A5053066981 @default.
• W2015423024 creator A5059194699 @default.
• W2015423024 creator A5073344894 @default.
• W2015423024 creator A5080679568 @default.
• W2015423024 creator A5082442667 @default.
• W2015423024 creator A5091095213 @default.
• W2015423024 date "2010-03-11" @default.
• W2015423024 modified "2023-10-06" @default.
• W2015423024 title "The tyrosine kinase inhibitor dasatinib dysregulates bone remodeling through inhibition of osteoclasts in vivo" @default.
• W2015423024 cites W1560301770 @default.
• W2015423024 cites W1969334819 @default.
• W2015423024 cites W1970595617 @default.
• W2015423024 cites W1974005588 @default.
• W2015423024 cites W1976136448 @default.
• W2015423024 cites W1976152802 @default.
• W2015423024 cites W1982266469 @default.
• W2015423024 cites W1984858901 @default.
• W2015423024 cites W1987577114 @default.
• W2015423024 cites W1988750150 @default.
• W2015423024 cites W1997107243 @default.
• W2015423024 cites W1998356799 @default.
• W2015423024 cites W2000170431 @default.
• W2015423024 cites W2003092614 @default.
• W2015423024 cites W2003973314 @default.
• W2015423024 cites W2004190331 @default.
• W2015423024 cites W2005297452 @default.
• W2015423024 cites W2006917576 @default.
• W2015423024 cites W2008756438 @default.
• W2015423024 cites W2013300935 @default.
• W2015423024 cites W2020469763 @default.
• W2015423024 cites W2021430668 @default.
• W2015423024 cites W2023061695 @default.
• W2015423024 cites W2023229955 @default.
• W2015423024 cites W2025162592 @default.
• W2015423024 cites W2025173384 @default.
• W2015423024 cites W2028638661 @default.
• W2015423024 cites W2029620076 @default.
• W2015423024 cites W2031603575 @default.
• W2015423024 cites W2035492623 @default.
• W2015423024 cites W2038201345 @default.
• W2015423024 cites W2041138285 @default.
• W2015423024 cites W2049953991 @default.
• W2015423024 cites W2050508925 @default.
• W2015423024 cites W2060081258 @default.
• W2015423024 cites W2068747322 @default.
• W2015423024 cites W2070914367 @default.
• W2015423024 cites W2076378952 @default.
• W2015423024 cites W2080125373 @default.
• W2015423024 cites W2080907164 @default.
• W2015423024 cites W2092606584 @default.
• W2015423024 cites W2097946794 @default.
• W2015423024 cites W2101635775 @default.
• W2015423024 cites W2105332564 @default.
• W2015423024 cites W2114627676 @default.
• W2015423024 cites W2127298694 @default.
• W2015423024 cites W2132953937 @default.
• W2015423024 cites W2133351125 @default.
• W2015423024 cites W2133876644 @default.
• W2015423024 cites W2133940180 @default.
• W2015423024 cites W2141884093 @default.
• W2015423024 cites W2158132138 @default.
• W2015423024 cites W2171405465 @default.
• W2015423024 cites W2248615526 @default.
• W2015423024 cites W2412123300 @default.
• W2015423024 cites W41374793 @default.
• W2015423024 doi "https://doi.org/10.1002/jbmr.85" @default.
• W2015423024 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20225261" @default.
• W2015423024 hasPublicationYear "2010" @default.
• W2015423024 type Work @default.
• W2015423024 sameAs 2015423024 @default.
• W2015423024 citedByCount "77" @default.
• W2015423024 countsByYear W20154230242012 @default.
• W2015423024 countsByYear W20154230242013 @default.
• W2015423024 countsByYear W20154230242014 @default.
• W2015423024 countsByYear W20154230242015 @default.
• W2015423024 countsByYear W20154230242016 @default.
• W2015423024 countsByYear W20154230242017 @default.
• W2015423024 countsByYear W20154230242018 @default.
• W2015423024 countsByYear W20154230242019 @default.
• W2015423024 countsByYear W20154230242020 @default.
• W2015423024 countsByYear W20154230242021 @default.
• W2015423024 countsByYear W20154230242022 @default.
• W2015423024 countsByYear W20154230242023 @default.
• W2015423024 crossrefType "journal-article" @default.
• W2015423024 hasAuthorship W2015423024A5011048271 @default.
• W2015423024 hasAuthorship W2015423024A5053066981 @default.
• W2015423024 hasAuthorship W2015423024A5059194699 @default.
• W2015423024 hasAuthorship W2015423024A5073344894 @default.
• W2015423024 hasAuthorship W2015423024A5080679568 @default.
• W2015423024 hasAuthorship W2015423024A5082442667 @default.
• W2015423024 hasAuthorship W2015423024A5091095213 @default.
• W2015423024 hasBestOaLocation W20154230241 @default.
• W2015423024 hasConcept C126322002 @default.
• W2015423024 hasConcept C134018914 @default.
• W2015423024 hasConcept C170033053 @default.

• next